US$ 28.57
borrelia glutathione Novel Diagnosis of Lyme Disease: Potential for CAM Intervention New insights into Lyme disease
Description
PMC 165860

developed a nanoparticle drug delivery system loaded with curcumin and latanoprost, which effectively inhibit the expression of inflammatory factors and reduce ROS production in trabecular meshwork cells, proving its certain potential for the treatment of glaucoma

Further evidence that the blood/brain barrier impedes paraquat entry into the brain

The foods and drink with the highest risk include meat, seafood and alcohol
